CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery (REFRESH)
Sponsor: CytoSorbents, Inc
A NA clinical study on Elective Cardiac Surgery, this trial is completed. The trial is conducted by CytoSorbents, Inc and has accumulated 8 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CytoSorbents, Inc
For direct contact, visit the study record on ClinicalTrials.gov .